Skip to content

Progesterone

Crinone, Endometrin, Milprosa, Progestasert, Progesterone, Prometrium, Intrarosa (progesterone) is a small molecule pharmaceutical. Progesterone was first approved as Crinone on 1982-01-01. It is used to treat amenorrhea, endometrial hyperplasia, female infertility, and uterine hemorrhage in the USA. It has been approved in Europe to treat postmenopause. The pharmaceutical is active against progesterone receptor. In addition, it is known to target cation channel sperm-associated protein 3, mineralocorticoid receptor, cation channel sperm-associated protein 2, short transient receptor potential channel 5, cation channel sperm-associated protein 4, and cation channel sperm-associated protein 1. Crinone's patents are valid until 2030-01-21 (FDA).
Trade Name Intrarosa
Common Name Progesterone
Indication amenorrhea, endometrial hyperplasia, female infertility, postmenopause, uterine hemorrhage
Drug Class Progestins; steroids (androgens, anabolics)
Progesterone
Get full access now